Abstract:BackgroundKeloid is a benign proliferative disease characterized by excessive deposition of extracellular matrix collagen during skin wound healing. The mechanisms of keloid formation have not been fully elucidated, and the current treatment methods are not effective for all keloid patients. Therefore, there is an urgent need to find more effective therapies, and our research focused on identifying characteristic molecular signatures of keloid to explore potential therapeutic targets.MethodsGene expression profiles of keloid and control group samples were retrieved from the GEO database. Taking the GSE113619 dataset as the training set, the dataset collected skin tissues from non-lesion sites of healthy and keloid-prone individuals, denoted as Day0. The second sampling was performed 42 days later at the original sampling site of control and keloid groups, denoted as Day42.The 'limma' package and Venn diagram identified differentially expressed genes (DEGs) specific to keloid day42 versus day0 samples. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome pathway functional enrichment, and annotation of the characteristic genes were conducted on the Metascape website. Ingenuity canonical pathways, disease & function enrichment analysis and gene interaction network were performed and predicted in Ingenuity Pathway Analysis (IPA) software. Key module genes related to keloid were filtered out by Weighted Gene Co-expression Network Analysis (WGCNA). We utilized the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm to screen the characteristic genes in keloid by the ‘glmnet’ package. The area under the curve (AUC) of receiver operating characteristic (ROC) was utilized to determine the effectiveness of potential signatures in discriminating keloid samples from normal samples and performed by using the ‘pROC’ package. The enrich scores of 24 immune cells in each sample were calculated by the single-sample gene set enrichment analysis (ssGSEA) algorithm, and then the Gene Set Variation Analysis (GSVA) was performed. Finally, RNA from 4 normal and 6 keloid samples was extracted, and RT-qPCR and Western Blot validated the expression of characteristic genes.ResultsA total of 640 DEGs specific to keloid day42 versus day0 samples were detected. 69 key module genes were uncovered and implicated in ‘NCAM signaling for neurite out-growth’, ‘oncogenic MAPK signaling’, ‘transmission across chemical synapses’ pathways, and the mitotic cell cycle-related processes. Five characteristic genes (MTUS1, UNC5C, CEP57, NAA35, and HOXD3) of keloid were identified by LASSO, and among which UNC5C and HOXD3 were validated by ROC plot in external dataset, RT-qPCR and Western Blot in validation samples. The result of ssGSEA indicated that the infiltration of neutrophils showed a relatively higher abundance and natural killer cells with relatively low enrichment in the keloid group compared to the control group. UNC5C was correlated with more immune cells compared with other characteristic genes.ConclusionIn this study, characteristic genes associated with keloid were identified by bioinformatic approaches and verified in clinical validation samples, providing potential targets for the diagnosis and treatment of keloid.

Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma

Identification of Novel Potential Biomarkers in Infantile Hemangioma Via Weighted Gene Co-Expression Network Analysis

Identifying Potential Diagnostic and Therapeutic Targets for Infantile Hemangioma Using WGCNA and Machine Learning Algorithms

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation

Transcriptional data analysis reveals the association between infantile hemangiomas and venous malformations

Construction of Mirna-Mrna Regulatory Network to Identify Potential Biomarkers in Infantile Hemangioma by Integrated Bioinformatics Analysis

Long Noncoding RNA Expression Profile of Infantile Hemangioma Identified by Microarray Analysis

A novel hsa_circ_0006903 circular RNA promotes tumor development and dendritic cells activated expression in infantile hemangioma

A Weighted Gene Co-Expression Network Analysis for Identifying Hub Genes in Preeclampsia-Induced Intrauterine Growth Restriction

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

Expression profile of circular RNAs in infantile hemangioma detected by RNA-Seq.

A Common Polymorphism Within the IGF2 Imprinting Control Region is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas.

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma

Non-coding RNA in infantile hemangioma

Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis

Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study.

Weighted Gene Coexpression Network Analysis Reveals the Critical lncRNAs and mRNAs in Development of Hirschsprung's Disease

Screening and Identification of Biomarkers Associated with the Immune Infiltration of Intracerebral Hemorrhage

[Indentification of Differentially Expressed Genes in Proliferating and Involuting Hemangiomas by Cdan Microarray Analysis of Gene-Expression Profiles].

Angiogenin: a potential serum marker of infantile hemangioma revealed by cDNA microarray analysis.

Identification of differentially expressed genes in proliferating hemangiomas by cDNA microarray analysis of gene expression profiles